In the News

Updates on Cleerly in the News

Cleerly is aware of the lawsuit filed by Heartflow. We are confident in our extensive and well-established intellectual property portfolio and the originality of our technology.

Cleerly has published landmark clinical science that has redefined how cardiovascular disease is understood and treated, which has formed the basis of our novel technologies that provide physicians with actionable insights into their patients’ heart health.

Cleerly was founded on a mission to create a world without heart attacks, and we have never been more focused in our mission and committed to the patients and physicians who count on us.

For any questions, please reach out to press@cleerlyhealth.com

medtech

Hubspot names Cleerly Among 40 AI Startups To Watch Out For in 2023

Hubspot, an industry-leading software provider of tools that link marketing, sales and customer service, names Cleerly as one of the top 40 startups...

Read More